Healthcare Facilities company Krishna Institute of Medical Sciences announced Q2FY25 results Gross revenue of Rs 782 crore, a growth of 19.4% on YoY and 12.9% on QoQ basis. EBITDA of Rs 223 crore, a growth of 23.8% on YoY and 21.2% on QoQ basis. EBITDA margin at 28.5% vs. 27.5% in Q2FY24 and 26.6% in Q1FY25. EBITDA Margin (excluding Other Income) stands at 28.1% vs. 27.2% in Q2FY24 and 26.1% in Q1FY25. PAT at Rs 121 crore in Q2FY25 against Rs 101 crore and Rs 95 crore in Q2FY24 and Q1FY25 respectively. Consolidated EPS of Rs 3, a growth of 16.7% on YoY and 24.0% on QoQ basis. Cash and Cash Equivalents (includes Cash, Bank balance, Deposits with maturity less than 12 months and Investment in Mutual funds) at Rs 90 crore as on Q2FY25. B Bhaskar Rao, CMD, KIMS Hospitals, said: The second quarter has been an extremely busy and productive one on multiple fronts for us. Our unit in Nashik went live this quarter and we are happy to say that we have started our first hospital in Kerala at Kannur. All our units are working to their optimal capacity to meet the rush of patients across all geographies. We have been focusing on ensuring that our mission to provide affordable and accessible quality healthcare reaches everyone effectively. We are confident and on track to achieve our targets for FY25." Result PDF
Conference Call with Krishna Institute of Medical Sciences Management and Analysts on Q2FY25 Performance and Outlook. Listen to the full earnings transcript.